The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients ...

A new study found that getting a glass of milk's worth of calcium per day, whether or not it comes from dairy, can lower ...

As someone who has overcome colorectal cancer, I reflect on the support I received from others and vow to continue their ...

Where you store fat, as opposed to how much you have, may be a bigger risk factor for colon cancer, a study published in JAMA ...

The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for ...

Research shows that people with a certain body shape face a higher risk of serious health problems compared to their ...

The Phase III CodeBreaK 300 study returned disappointing overall survival data for Lumakras plus Vectibix in metastatic ...

Amgen (AMGN) stock in focus as U.S. approval for its lung cancer drug expands for metastatic colorectal cancer. Read more ...

The Galleri test — which isn’t covered by insurance — doesn’t come cheap. At $949 a pop, it’s out of the price range of most ...

The FDA has approved Lumakras with Vectibix for adults with KRAS G12C-mutated metastatic colorectal cancer who received ...

A new report shows that cancer cases are increasing in females in the United States and in younger adults. For the first time ...

The combination treatment specifically targets KRAS-mutated metastatic colorectal cancer (CRC) to improve progression-free ...